Pinned Tweet
#Antimicrobialresistance is a growing public health threat, making infections harder to treat and putting the effectiveness of life-saving medicines at risk. Building awareness is an important step towards encouraging more responsible action against #AMR.
1
359
#COPD can progress silently. Are you aware of your #LungHealth health? Persistent coughing, breathlessness, wheezing, or mucus production should not be ignored. Recognising symptoms and identifying potential risks can help encourage timely medical evaluation.
1
282
This #WorldCOPDDay , take Cipla’s 1-minute Digital Lung Health Screening to receive an indicative Lung Health Score, including the likelihood of asthma and COPD.
Know your Lung Health Score. Take the first step towards better lung health. 🔗 lnkd.in/dmj9qxbj
1
28
Breathing better starts with recognising the signs early. On #WorldCOPDDay, our teams across markets are strengthening different parts of the COPD care journey, from screening & early detection to education, disease management & rehabilitation.
Read more: lnkd.in/p/d6XTk8Ka
205
Tackling #AMR takes more than one intervention. It requires responsibility across the entire antimicrobial journey.
At Cipla, this starts with working to expand access to essential medicines and strengthening our portfolio to address unmet needs in resistant infections.
1
307
It extends to antimicrobial stewardship, where we work with healthcare professionals to encourage appropriate use and strengthen awareness. And it continues into how antibiotics are manufactured, with measures designed to minimise their impact on the environment.
1
25
These efforts are connected by a shared purpose of Caring for Life, thereby preserving the effectiveness of antimicrobials so they can continue to serve patients who need them, today & in the future.
#IACTMoreResponsibly #AMR #AntiMicrobialResistance #WAAW2026 #AMR #CaringforLife
21
It extends to antimicrobial stewardship, where we work with healthcare professionals to encourage appropriate use and strengthen awareness. And it continues into how antibiotics are manufactured, with measures designed to minimise their impact on the environment.
1
29
These efforts are connected by a shared purpose of Caring for Life, thereby preserving the effectiveness of antimicrobials so they can continue to serve patients who need them, today & in the future.
#IACTMoreResponsibly #AMR #AntiMicrobialResistance #WAAW2026 #AMR #CaringforLife
21
This World AMR Awareness Week, under the WHO theme "OneHealth, One Action: Prevent AMR Now,” Cipla supports the call for collective action across human, animal and environmental health. Because addressing AMR needs all of us to act, and act responsibly.
#WAAW2026 #Caringforlife
39
A global presence, a diverse portfolio, and over nine decades of making a difference.
Cipla continues to expand its reach, bringing quality healthcare solutions closer to people and addressing unmet patient needs across markets.
#CaringForLife #StrongLegacyStrongerFuture
412
At Cipla, every milestone begins with our people.
Behind every breakthrough is a team of more than 30,000 passionate employees across the globe that bring care, collaboration and commitment to everything they do.
Together, we're shaping the future of healthcare.
#CaringForLife
1
1
373
From R&D to new product launches and regulatory excellence, every milestone reflects our commitment to turning that trust into meaningful healthcare solutions for patients around the world. #CaringForLife
48
Cipla Patalganga Unit 1 & Unit 2 have been recognised with the Certificate of Merit at the Maharashtra Safety Awards 2025 for Achieving Zero Incident Rate in the Contest Year.
Cipla’s Goa-2 site has been recognised for the Most Outstanding Performance in the Manufacturing OH&S Excellence Award category at the WSO India OHS&E Awards 2026.
335
Cipla recognised with the Commute Safety Excellence Award at the Mobility Symposium 2026 Change Maker Awards for promoting safer journeys across our plant transport network nationwide.
332
We are pleased to share that we continue to make considerable progress across our focused markets.
Our focus remains on sustained growth, improving productivity & strengthening our pipeline in order to serve patients with trusted, high-quality medicines.- Achin Gupta, MD GCEO
484























